About us

NEWS

13 July 2011

EPO grants patent for gp130 muteins   [more]

14 December 2010

Three new patents granted in Japan, the USA and Europe [more]

23 June 2010

EPO grants patent for sgp130 variants [more]

Last update: December 21, 2011

CONARIS has been founded in 1999 and is a spin-off from the University Hospital of Schleswig-Holstein, Germany. The company is located in the Innovation and Technology Center of Kiel (KITZ) and is engaged in the preclinical and early clinical development of  innovative drugs with a special focus on inflammatory indications.

Deutsch
Kieler Innovations- und Technologiezentrum (KITZ)